Janardhan S - Search Results

Year	Number of Results
1996	1
2003	1
2006	2
2007	1
2009	1
2010	1
2011	2
2013	4
2014	4
2015	4
2016	4
2017	2
2018	2
2019	5
2020	2
2021	3
2022	4
2023	4
2024	3

1

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.

Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K; CONFIRM Study Investigators. Wong F, et al. N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290. N Engl J Med. 2021. PMID: 33657294 Clinical Trial.

2

Common Misconceptions in Hepatology: Nonalcoholic Fatty Liver Disease.

Janardhan SV. Janardhan SV. Clin Liver Dis (Hoboken). 2019 Mar 29;13(3):79-81. doi: 10.1002/cld.769. eCollection 2019 Mar. Clin Liver Dis (Hoboken). 2019. PMID: 30988942 Free PMC article. Review. No abstract available.

3

Ketamine as an Adjunct for Treatment of Methotrexate-induced Neurotoxicity.

Ilahi Z, Janardhan S, Dave M, Khariton M, Feuer P, Venkataraman A, Romanos-Sirakis E. Ilahi Z, et al. Among authors: janardhan s. J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e512-e513. doi: 10.1097/MPH.0000000000002366. J Pediatr Hematol Oncol. 2022. PMID: 35200225

4

Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort.

Sanyal AJ, Munoz B, Cusi K, Barritt AS 4th, Muthiah M, Mospan AR, Reddy KR, Firpi-Morell R, Thuluvath PJ, Bhamidimarri KR, Fried MW; TARGET-NASH Investigators. Sanyal AJ, et al. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2889-2900.e10. doi: 10.1016/j.cgh.2023.02.024. Epub 2023 Mar 5. Clin Gastroenterol Hepatol. 2023. PMID: 36871772

5

Urinary Tract Infections in Low Birth Weight Neonates.

Janardhan S, Kim S, Cukovic B, Demissie S, Roth P, Blau J. Janardhan S, et al. Am J Perinatol. 2022 Dec 29. doi: 10.1055/s-0042-1757454. Online ahead of print. Am J Perinatol. 2022. PMID: 36580976

6

Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Berger D, Desai V, Janardhan S. Berger D, et al. Among authors: janardhan s. Clin Liver Dis (Hoboken). 2019 Apr 30;13(4):114-116. doi: 10.1002/cld.740. eCollection 2019 Apr. Clin Liver Dis (Hoboken). 2019. PMID: 31061705 Free PMC article. Review. No abstract available.

7

Choline kinase: an important target for cancer.

Janardhan S, Srivani P, Sastry GN. Janardhan S, et al. Curr Med Chem. 2006;13(10):1169-86. doi: 10.2174/092986706776360923. Curr Med Chem. 2006. PMID: 16719778 Review.

8

Recent Advances in the Development of Pharmaceutical Agents for Metabolic Disorders: A Computational Perspective.

Janardhan S, Dubovskaja V, Lagunin A, Rao BV, Sastry GN, Poroikov V. Janardhan S, et al. Curr Med Chem. 2018;25(39):5432-5463. doi: 10.2174/0929867324666171002120647. Curr Med Chem. 2018. PMID: 28969540 Review.

9

Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment.

Janardhan S, Sastry GN. Janardhan S, et al. Curr Drug Targets. 2014 Jun;15(6):600-21. doi: 10.2174/1389450115666140311102638. Curr Drug Targets. 2014. PMID: 24611684 Review.

10

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.

Mayo MJ, Carey E, Smith HT, Mospan AR, McLaughlin M, Thompson A, Morris HL, Sandefur R, Kim WR, Bowlus C; TARGET-PBC Investigators; Levy C. Mayo MJ, et al. Dig Dis Sci. 2023 Mar;68(3):995-1005. doi: 10.1007/s10620-022-07581-x. Epub 2022 Jun 15. Dig Dis Sci. 2023. PMID: 35704252 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year